Valid animal models are useful for studying the pathophysiology of specific disorders, such as neural disease, diabetes and cancer. Previous molecular phylogeny studies indicate that the tree shrew is in the same order as (or a close sister to) primates, and thus may be an ideal model in which to study human disease. In this study, the proteome of liver and muscle tissue in tree the shrew was identified by combining peptide fractionation and LC-MS/MS identification. In total, 2146 proteins were detected, including 1759 proteins in liver samples and 885 proteins in skeletal muscle samples from the tree shrew. Further sub-source analysis revealed that nearly half of the identified proteins (846 proteins and 418 proteins) were derived from human database. In this study, we are the first to describe the characteristics of the proteome from the liver and skeletal muscle of the tree shrew. Phylogenetic tree analysis based on these proteomic data showed that the tree shrew is closer to primates (human) than to glires (the mouse and rat).
INTRODUCTION
The tree shrew is a small diurnal mammal found primarily in the tropical forests of Southeast Asia. This geographic region includes southwest China, Burma, Indonesia, and the Philippines . Previous biological studies have indicated that the tree shrew is in the same order as primates, which contains the closest relatives to humans (Janecka et al., 2007) . Many tree shrew (Tupaia belangeri chinensis) populations are distributed throughout the Yunnan, Hainan, Guizhou, and Tibet provinces in China (Helgen et al., 2005) . Therefore, it is would be valuable to establish a tree shrew model for human disease, learning and memory processes, and the preclinical evaluation of new drugs.
The liver and skeletal muscle are the target organs of many diseases that have been studied using proteomic strategies; these include diabetes (Deng et al., 2010; Lu et al., 2012) , hepatic carcinoma (Liu et al., 2010; Li et al., 2011) , neuro myotonia (Tieleman et al., 2009) , neurogenic muscular atrophy (Staunton et al., 2011; Wu et al., 2011) , and myotonic syndrome (Orengo and Cooper, 2007) . Many significant findings have been obtained using animal models; however, little of this work has been successfully translated into clinical practice (van der Worp et al., 2010) . Proteomic techniques allow a large-scale analysis of protein expression at the tissue, cell or organ level. It is then possible to globally visualize the mechanisms used by the cell to resolve the problems under various physiological and pathological conditions (Lescuyer et al., 2004) . The success of proteomic methodology has relied on the rapid development of several technical areas, principally related to protein identification by mass spectrometry (MS). MS techniques themselves have improved as a result of progress made in sample preparation (Shevchenko et al., 1996; Zhang et al., 1999) and the development of methods that have increased the amount and quality of data obtained by MS analysis (Kennedy and Jorgenson, 1989; Wilkins et al., 1996; Wilm and Mann, 1996) . In this study, the proteome of the liver and muscle of the tree shrew was characterized by combining OFFGEL peptide fractionation and LC-MS/MS identification. In total, 2146 proteins were detected, including 1759 liver proteins and 885 muscle proteins. This study is the first characterization and description of the tree shrew proteome.
RESULTS

Proteomic characterization of the liver and skeletal muscle of the tree shrew
We undertook the study of liver and skeletal muscle using IEF-LC-MS/MS to determine the tree shrew proteomic profile and to compare differences between the liver tissue and the skeletal muscle tissue in the tree shrew. To reduce sample complexity, the proteins in the liver and skeletal muscle samples were first prepared for analysis using in-solution trypsin digestion. The resultant peptide mixtures were fractionated by IEF OFFGEL electrophoresis (Fig. 1) . In this study, we established an integrated database by combining four Uniprot databases, from the human, common chimpanzee, rat and mouse. Overall, 50,476 peptides and 8024 unique peptides were corresponding to 2146 proteins. Then, the proteomic data were scanned according to the source, obtaining 1759 proteins (24,444 peptides and 5560 unique peptides) in the liver and 885 proteins (27,474 peptides and 3760 unique peptides) in the skeletal muscle of the tree shrew ( Fig. 2A , Table  S1 and S2). As shown in Fig. 2B , 1236 unique peptides overlapped between the liver and skeletal muscle in the tree shrew.
Sub-source investigation of the proteome of tree shrew liver and skeletal muscle
We further divided the liver proteomic data and the skeletal muscle proteomic data into proteins that were similar to those in the four individual sub-source species databases (human, chimpanzee, rat and mouse). As shown in Fig. 3A , at the peptide level, the human, rat and mouse databases contained a similar proportion and number of the unique peptides identified in the tree shrew. Of the four species databases, the common chimpanzee database contained the lowest proportion and number of unique peptides identified in the tree shrew. At the protein level, nearly half of the identified proteins (1017 liver proteins and 694 skeletal muscle proteins) were highly similar to those found in humans (Fig. 3B) , whereas only one quarter of the tree shrew proteins identified were highly similar to those in the mouse and rat. Similar to the peptide distribution, less than 10% of the identified tree shrew proteins were present in the common chimpanzee species. Furthermore, the overlapping in all three species (human, mouse and rat) of unique peptide sequences was similar in the liver and skeletal muscle ( Fig. 3C and 3D ). Within the tree shrew peptide data, 61.42% (3415) and 55.08% (2071) of the unique peptides were found in the liver and skeletal muscle of all four species. Of the total proteomic database, 18.29% (1017/5560) of the proteins from the tree shrew liver and 18.46% (694/3760) of the proteins from the skeletal muscle were present only in humans, and these are higher proportions than found in the other three species (Fig.  4) .
Biological annotation of the proteomic profile in the liver and skeletal muscle of the tree shrew
The identified proteins were functionally categorized based on the universal Gene Ontology annotation and KEGG pathway terms, using DAVID analysis software (http://david. abcc.ncifcrf.gov/). For each biological annotation, we selected ten significantly enriched terms for both the liver and the skeletal muscle (Fig. 5) . The X-Value (-Log (P value)) and percentage of identification were determined to assess the differential function of the liver and skeletal muscle in the tree shrew. Several metabolic and biosynthetic processes were mainly enriched in the liver than in the skeletal muscle. Several terms involving maintenance of cellular location and biological regulation were primarily enriched in the skeletal muscle (Fig. 5A ). In the analysis of cellular components, the terms ribonucleoprotein complex, membrane-bounded organelles, organelle membranes and organelle envelopes were uniquely enriched in the liver. However, those related to the extracellular matrix, cell projection, cell leading edge and non-membrane-bounded organelles were found only enriched in the skeletal muscle (Fig. 5B) . In the analysis of molecular function, the terms carboxylic acid binding, nucleic acid binding, lyase activity and translation factor activity were more enriched in the liver than the muscle, and terms relating to structural constituents of the cytoskeleton, to protein binding and to structural constituents of the skeletal muscle were only enriched in the muscle compared to the liver (Fig. 5C ). Within the KEGG pathway data, metabolism-related terms such as fatty acid metabolism, citrate cycle (TCA cycle) and Glycolysis/Gluconeogenesis were enriched in the liver. Disease-related terms such as cardiomyopathy, Alzheimer's disease and Huntington's disease were enriched in the skeletal muscle (Fig. 5D) .
Because of the extensive annotation available, the KEGG pathway database was especially valuable for revealing the networks to which the identified proteins belong. The z-score was used to determine the significance of the enrichment of the pathway terms. For higher-dimensional arrays, z-scores are computed using the mean and standard deviation along the first non-singleton dimension. Next, the enriched characterizations for the KEGG pathway were presented according to the sub-source: human (hsa), mouse (mmu) or rat (rno). As shown in Fig. 6 , although the metabolisic processes were main processes that were enriched in the liver, there were differences between the human, mouse and rat. Overall, the mouse data than to the rat data were more similar to the human data in our proteomic data of tree shrew. Furthermore, signaling pathways were main processes that were enriched in the muscle, and a differential pattern was present in the skeletal muscle data for the three species.
Phylogenetic tree
The phylogenetic tree containing representative species within Euarchonta and Glires is shown in Fig. 7A and 7B. We included two representatives of the primate order (human and tree shrew) as well as two representatives of the Glires clade (mouse and rat) for comparison with our sequences.
We observed a strong phylogenetic signal (based on the UPGMA method) for the peptide sequences of our proteomic data. In the UPGMA tree, the human and tree shrew formed a sister clade, in contrast to the mouse and rat both in liver and skeletal muscle samples. This pattern was also reported in previous studies that used the complete mitochondrial genome (Xu et al., 2012) or mammalian mitogenomic relationships (Abascal et al., 2005) .
DISCUSSION
Defining suitable models for the study of human diseases is important. Because of ethical and environmental concerns, animal models will continue to be used in biomedical research for the foreseeable future. Considering the restrictions on the use of nonhuman primates, it is critical to find an alternative animal for biomedical research. Such an alternative will need various features, such as availability, cost-effectiveness, easy maintenance, and most importantly, evolutionary closeness to humans (Xu et al., 2012) . As the representative species of Scandentia, the tree shrew shares some characteristics of both the ancestral and modern primates (Murphy et al., 2001; Cao et al., 2003; Janecka et al., 2007) . In addition, tree shrews also have several features that are unique among experimental animals and have long been proposed as an ideal substitute for nonhuman primates in biomedical research and safety testing (Cao et al., 2003) . Because the sequencing of the tree shrew genome has not been completed, we used an integrated database combined by human, chimpanzee, rat and mouse database. This strategy not only provided a searchable resource database but also revealed necessary evolutionary information to elucidate the relationship between the tree shrew and humans. © Higher Education Press and Springer-Verlag Berlin Heidelberg 2012 By combining proteomic databases from relevant tissue sources, we not only uncovered various tree shrew proteins, including functionally important proteins but also assessed the characteristics of these proteins in the liver and skeletal muscle. The physicochemical characteristics of the proteome were similar in the liver and skeletal muscle (Fig. 3A-3C) . However, the functional annotation was markedly different between the liver and skeletal muscle: metabolism and synthesis processes were enriched in the liver, whereas cellular signal transduction and related pathways were enriched in the skeletal muscle (Fig. 6) . Furthermore, we divided the proteomic data according to the sub-source (human, chimpanzee, rat and mouse database) and compared these data with those of four species. Nearly half of the identified proteins (868 liver proteins and 418 muscle proteins) were present in humans. Within these data, the protein coverage of liver proteins identified in the human database was far higher than that identified in the database for other species. On © Higher Education Press and Springer-Verlag Berlin Heidelberg 2012 analysis of KEGG pathways, we found metabolism-related factors were mainly enriched in the liver, with differences between the human, mouse and rat. The mouse data showed more similarity with the human data than with the rat data. In addition, the related signaling pathways were mainly enriched in the skeletal muscle, and a differential pattern was present in all three species' muscle tissue. Here, our studies shown that metabolic process can be studied in the liver tissue of the tree shrew, whereas the skeletal muscle seems to be an excellent choice for signal transduction research. In addition previous studies have explored the genetic similarity of tree shrews to primates by sequencing the entire mtDNA genome of Chinese tree shrews and comparing it to that of other species in Euarchontoglires (Schmitz et al., 2000; Arnason et al., 2002; Xu et al, 2012) . Our findings, based on proteomic data, reveals that the tree shrew is more closely related to primates (the human and common chimpanzee) than to Glires (the mouse and rat).
MATERIALS AND METHODS
Sample preparation
Liver and skeletal muscle tissues were obtained from tree shrews at 9 weeks of age. The liver and skeletal muscle tissues were cut into small pieces and washed with PBS. Samples were frozen using liquid nitrogen and ground to powder. This powder was lysed in SDT-lysis buffer (2% SDS, 0.1 mol/L DTT, and 0.1 mol/L Tris-HCl, pH = 7.6). After vortexing, the samples were homogenized for approximately 3 min and then sonicated at 100 w × 30 s and centrifuged at 15,000 g for 1 h. The protein concentration was determined by measurement of tryptophan fluorescence as described previously (Nielsen et al., 2005) . Briefly, 1 μL of sample or tryptophan standard (100 ng/μL) was added to 3 mL of 8 mol/L urea buffer (8 mol/L urea, and 20 mmol/L Tris-HCl, pH = 7.6). The dye was excited at 295 nm, and the fluorescence was measured at 350 nm. The slits were set at 10 nm.
In-solution tryptic digestion
Four hundred micrograms of mixed sample was digested by the FASP procedure as described previously (Wisniewski et al., 2009) . Each sample was transferred to a 10-k filter (Pall Corporation) and centrifuged at 10,000 g for 20 min at 20°C. UA buffer (200 μL) (8 mol/L urea and 0.1 mol/L Tris-HCl, pH = 8.5) was added, and the sample was centrifuged at 10,000 g for 20 min again. This step was repeated once. The concentrate was then mixed with 100 μL of 50 mmol/L IAA in UA buffer and incubated for an additional 40 min at room temperature in the dark. Next, the IAA was removed by centrifugation at 10,000 g for 20 min. Following two rounds of dilution in 200 μL of UA buffer and centrifugation, 200 μL of 50 mmol/L NH4HCO3 was added to the sample, which was then centrifuged at 10,000 g for 20 min. This step was repeated twice. Finally, 100 μL of 50 mmol/L NH 4 HCO 3 and trypsin (1:25, enzyme to protein) was added, and the mixture was incubated at 37°C for 20 h. The tryptic peptide mixtures were collected for further analysis Peptides from each fraction (30 μg) were desalted by stage-tip (Rappsilber et al., 2007) . After lyophilization, one-third of the peptide sample was loaded onto an RP column and analyzed via mass spectrometry.
Peptide OFFGEL fractionation
For pI-based peptide separation, we used the 3100 OFFGEL Fractionator (Agilent Technologies, Böblingen, Germany) with a 12-well set-up. For the 12-well set-up, peptide samples were diluted to a final volume of 1.8 mL using OFFGEL peptide sample solution. To start, 13-cm long IPG gel strips (GE Healthcare, München, Germany) with a linear pH range of 3-10 were rehydrated with Peptide IPG Strip Rehydration Solution according to the manufacturer's protocol for 60 min. Then, 150 μL of sample was loaded in each well. Electrofocusing of the peptides was performed at 20°C and 50 μA until the 100 kVh level was reached. After focusing, the 11th fraction was withdrawn owing to a lack of solution in this well). The rinses in each well were pooled with their corresponding peptide fraction. All fractions were evaporated by centrifugation under vacuum and maintained at -20°C. Prior to MS analysis, the samples were desalted onto an Empore C18 47-mm Disk (3 mol/L). Immediately prior to nano-LC, the fractions were suspended in 20 μL of H2O containing 0.1% (v/v) TFA.
Label-free shotgun proteomic identification
Each IEF fraction containing peptides was dissolved in 60 μL 0.1% formic acid, and then half of this peptide solution was loaded onto an RP column. RP-HPLC was performed using an Agilent 1100 Capillary system (Agilent technologies) with a homemade tip column (15 cm in length, 75 µm inner diameter) packed with ReproSil-Pur C18-AQ 3-μm resin (Dr. Maisch GmbH) in 100% methanol. The pump flow rate was 1.6 μL/min. Mobile phase A was 0.1 % formic acid in water, and mobile phase B was 0.1% formic acid in acetonitrile. The tryptic peptide mixtures were eluted using a gradient of 2%-55% B over 180 min. Mass spectral data were acquired on an LTQ linear ion trap mass spectrometer (Thermo, San Jose, CA) equipped with an electrospray interface operated in positive ion mode. The temperature of the heated capillary was set at 170°C, and a voltage of 3.0 kV was applied to the ESI needle. The normalized collision energy was 35. The number of ions stored in the ion trap was regulated by the automatic gain control. The voltages across the capillary and the quadrupole lenses were tuned by an automated procedure to maximize the signal for the ion of interest. The mass spectrometer was set to one full MS scan followed by MS/MS scans on the ten most intense ions from the MS spectrum with the following Dynamic Exclusion™ settings: repeat count, 2; repeat duration, 0.5 min; and exclusion duration, 1.5 min.
Data analysis
The acquired MS/MS spectra were compared with a modified Uniprot database combining human, common chimpanzee, mouse, and rat data (ftp://ftp.uniprot.org/pub/databases/uniprot/previous_releases/ release-2012_03/knowledgebase/); the data included sequences of real proteins and reverse sequences of proteins, via the Mascot program. For this comparison, carbamidomethyl cysteine was used as a fixed modification and oxidized methionine as a variable modi-fication (Perkins et al., 1999) . Up to two internal cleavage sites were allowed for tryptic searches. All output results were combined using in-house software named BuildSummary to delete redundant data. Searches were conducted against the modified Uniprot database to maintain the false discovery rate at 5%. All spectral peptide counts had a ∆Cn score of at least 0.1. Peptides with scores ≥25 were considered to have high homology. Protein identifications were accepted if the false discovery rate was less than 5% and a minimum of one peptide met the identity threshold.
Bioinformatics analysis
Biological function enrichment analysis was performed using David (http://david.abcc.ncifcrf.gov/). In this study, the following formula was used to determine z-scores, z = (X -mean(X))/std(X), and the output was used as a representative value of pathway enrichment.
Phylogenetic tree analysis
We used the number of shared peptides between the tree shrew, human, mouse and rat to construct the phylogeny for the species in liver and skeletal muscle, respectively. We treated the presence or absence of a peptide in each species as (1,0) two-state character, and the characters were concatenated into linear sequences. We applied the UPGMA method implemented in MEGA for the phylogeny construction, and the distance was chosen as the number of different peptides between species.
